|
2B5I
cytokine receptor complex
Deposited 2005-09-28
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
56–254(199 aa)
|
Mutation:N53Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.1;293 K;29% Pentaerythritol Ethoxylate 15/4; 50 mM Ammonium Sulfate; 50 mM Bis Tris, pH 6.1, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 2.30 Å
R-free 0.269
|
|
2ERJ
Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2
Deposited 2005-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
23–255(233 aa)
|
Mutation:N58Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.1;295.5 K;MPEG 550, sodium acetate, sodium citrate, phenol, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 3.00 Å
R-free 0.263
|
|
2ERJ
Crystal structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2
Deposited 2005-10-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
23–255(233 aa)
|
Mutation:N58Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.1;295.5 K;MPEG 550, sodium acetate, sodium citrate, phenol, pH 5.1, VAPOR DIFFUSION, SITTING DROP, temperature 295.5K
|
Resolution 3.00 Å
R-free 0.263
|
|
3BPL
Crystal structure of the IL4-IL4R-Common Gamma ternary complex
Deposited 2007-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
56–254(199 aa)
Fragment:Extracellular domain, residues 56-254
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;295 K;10% PEG8K, 8% ethylene glycol, 0.1M HEPES pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
Resolution 2.93 Å
R-free 0.297
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 10
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain d
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 11
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain g
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 12
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain j
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain L
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain O
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain R
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain U
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain X
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
3QAZ
IL-2 mutant D10 ternary complex
Deposited 2011-01-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 9
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain a
56–254(199 aa)
Fragment:unp residues 56-254
|
Mutation:N75Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;100 mM Bis-Tris, 200 mM NH4SO4, 25% PEG-3350, pH 5.5, VAPOR DIFFUSION, SITTING DROP, temperature 298K
|
Resolution 3.80 Å
R-free 0.344
|
|
4GS7
Structure of the Interleukin-15 quaternary complex
Deposited 2012-08-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
55–254(200 aa)
|
Mutation:N75Q
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
EDO 1,2-ETHANEDIOL × 1
ACT ACETATE ION × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.75;298 K;22.5% PEG3350, 0.1M BIS-TRIS propane, 0.2M sodium acetate, pH 8.75, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.35 Å
R-free 0.227
|
|
5M5E
Crystal structure of a interleukin-2 variant in complex with interleukin-2 receptor
Deposited 2016-10-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
23–262(240 aa)
|
Not recorded
|
MAN alpha-D-mannopyranose × 1
SO4 SULFATE ION × 4
CYS CYSTEINE × 1
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;0.1M HEPES, pH 7.0, 2M ammonium sulfate
|
Resolution 2.30 Å
R-free 0.235
|
|
6OEL
Engineered Fab bound to IL-4 receptor
Deposited 2019-03-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain C
61–249(189 aa)
Fragment:UNP residues 61-249
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
NO3 NITRATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;295 K;22.5% PurePEG (Microlytic), 0.1 M sodium citrate, pH 5.5, 0.6 M ammonium nitrate
|
Resolution 3.10 Å
R-free 0.256
|
|
7S2R
nanobody bound to IL-2Rg
Deposited 2021-09-03
|
Different construct
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
55–254(200 aa)
Fragment:extracellular domain
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
SO4 SULFATE ION × 8
GOL GLYCEROL × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.5;295 K;2M ammonium sulfate, 0.2M BIS-Tris pH5.5
|
Resolution 2.49 Å
R-free 0.271
|
|
8ENT
Interleukin-21 signaling complex with IL-21R and IL-2Rg
Deposited 2022-09-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
55–254(200 aa)
|
Mutation:N53Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å
R-free 0.300
|
|
8ENT
Interleukin-21 signaling complex with IL-21R and IL-2Rg
Deposited 2022-09-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
55–254(200 aa)
|
Mutation:N53Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
EDO 1,2-ETHANEDIOL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å
R-free 0.300
|
|
8ENT
Interleukin-21 signaling complex with IL-21R and IL-2Rg
Deposited 2022-09-30
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain I
55–254(200 aa)
|
Mutation:N53Q
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;295 K;0.1M Tris pH 8, 20% PEG 6000
|
Resolution 2.83 Å
R-free 0.300
|
|
8EPA
Structure of interleukin receptor common gamma chain (IL2Rgamma) in complex with two antibodies
Deposited 2022-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain I
23–262(240 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
9E2T
Structure of a de novo designed interleukin-21 mimetic complex with IL-21R and IL-2Rg
Deposited 2024-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
55–254(200 aa)
Fragment:residues 55-254
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4
EDO 1,2-ETHANEDIOL × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;0.2M Potassium thiocyanate, 0.1M Bis-Tris propane, pH 6.5, 20% w/v PEG 3350
|
Resolution 2.28 Å
R-free 0.242
|
|
9E2T
Structure of a de novo designed interleukin-21 mimetic complex with IL-21R and IL-2Rg
Deposited 2024-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
55–254(200 aa)
Fragment:residues 55-254
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 3
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;298 K;0.2M Potassium thiocyanate, 0.1M Bis-Tris propane, pH 6.5, 20% w/v PEG 3350
|
Resolution 2.28 Å
R-free 0.242
|
|
9JQT
Structure of interleukin receptor common gamma chain (IL2Rgamma/CD132) in complex with 2D4
Deposited 2024-09-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
23–262(240 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
9KMC
Cryo-EM structure of the heterotrimeric interleukin-2 receptor in complex with interleukin-2 and anti-CD25 Fab S417
Deposited 2024-11-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain C
23–255(233 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.97 Å
|